Christian Marth

Research interests

Publications

• ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025

  The Lancet Oncology · 2025 · 10.1016/s1470-2045(25)00167-6

• ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

  Annals of Oncology · 2024 · https://doi.org/10.1016/j.annonc.2023.11.015

• Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

  Annals of Oncology · 2023 · 10.1016/j.annonc.2023.05.005

• Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2022 · 10.1016/j.annonc.2022.05.009

• European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.11.013

• ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

  International Journal of Gynecological Cancer · 2020 · https://doi.org/10.1136/ijgc-2020-002230

• A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1808424

• European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

  International Journal of Gynecological Cancer · 2017 · https://doi.org/10.1097/igc.0000000000001041

• Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1611310

• ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

  International Journal of Gynecological Cancer · 2015 · https://doi.org/10.1097/igc.0000000000000609

• Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)60995-3

• ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

  Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv484

• Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70244-x

• Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.55.7348

• 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer

  International Journal of Gynecological Cancer · 2011 · 10.1097/igc.0b013e31821b2568

• Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer

  Genome Research · 2010 · 10.1101/gr.103606.109

• Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.28.4273

• Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

  The Lancet Oncology · 2008 · 10.1016/s1470-2045(08)70204-3

• FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer

  Cancer Research · 2007 · 10.1158/0008-5472.can-07-1320

• Epigenetic stem cell signature in cancer

  Nature Genetics · 2006 · 10.1038/ng1941

• The Expression of the Regulatory T Cell–Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer

  Clinical Cancer Research · 2005 · https://doi.org/10.1158/1078-0432.ccr-05-1244

• A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050434

• Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

  Cancer Research · 2004 · 10.1158/0008-5472.can-03-3852

• Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

  Annals of Oncology · 2003 · https://doi.org/10.1093/annonc/mdg112

• DNA methylation in serum of breast cancer patients: an independent prognostic marker.

  PubMed · 2003

• hCDC4 gene mutations in endometrial cancer.

  PubMed · 2002

• Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

  Cancer · 1999 · 10.1002/(sici)1097-0142(19990101)85:1<178::aid-cncr25>3.0.co;2-7

Current projects

No projects listed.